Convalescent Plasma Collection and Treatment in Pediatrics and Adults

PHASE3RecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

April 16, 2020

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions
COVID19Coronavirus InfectionCoronavirusVirus DiseasesRNA Virus Infections
Interventions
BIOLOGICAL

Convalescent Plasma 1 Unit

"Each adult recipient will receive 1 units of plasma, each unit will consist of about 200 to 250 mL.~Each pediatric recipient will receive 10mL/kg up to 1 unit of plasma."

BIOLOGICAL

Convalescent Plasma 2 Units

"Those that meet severe or critical criteria will be given 2 units if available or 1 unit if 2 units are not available.~Those that are given 1 unit may receive the second unit (or the remainder of the maximum pediatric weight calculated amount of plasma up to 1 additional unit) if they progress to severe or critical condition or if already in severe or critical condition but only received 1 unit secondary to shortages.~Each pediatric recipient will receive 10mL/kg up to 2 units of plasma."

OTHER

Standard of Care

Those that meet mild severity will be allowed to enroll in the study, but will not receive plasma unless there is progression of illness into the moderate/rapid progression or greater category.

Trial Locations (1)

26506

RECRUITING

WVU Medicine, Morgantown

All Listed Sponsors
lead

West Virginia University

OTHER